A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens

Allergic DiseasesImmunotherapyT Cells

Der p 1-specific regulatory T cell response during house dust mite allergen immunotherapy

Allergy.

Boonpiyathad T, Sokolowska M, Morita H, Rückert B, Kast JI, Wawrzyniak M, Sangasapaviliya A, Pradubpongsa P, Fuengthong R, Thantiworasit P, Sirivichayakul S, Kwok WW, Ruxrungtham K, Akdis M, Akdis CA

doi: 10.1111/all.13684.

Allergic Diseases

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy

Allergy.

Rudulier CD, Tonti E, James E, Kwok WW, Larché M

doi: 10.1111/all.13867.

T Cells

The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy

J Allergy Clin Immunol.

Bacher P, Scheffold A

doi: 10.1016/j.jaci.2018.10.016.

Allergic Diseases

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

J Allergy Clin Immunol

Demoly P, Corren J, Creticos P, De Blay F, Gevaert P, Hellings P, Kowal K, Le Gall M, Nenasheva N, Passalacqua G, Pfaar O, Tortajada-Girbés M, Vidal C, Worm M, Casale TB

doi: 10.1016/j.jaci.2020.07.036

Allergic Diseases

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

J Allergy Clin Immunol.

Demoly P, Corren J, Creticos P, De Blay F, Gevaert P, Hellings P, Kowal K, Le Gall M, Nenasheva N, Passalacqua G, Pfaar O, Tortajada-Girbés M, Vidal C, Worm M, Casale TB

doi: 10.1016/j.jaci.

Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation

PLoS One.

Koparde V, Abdul Razzaq B, Suntum T, Sabo R, Scalora A, Serrano M, Jameson-Lee M, Hall C, Kobulnicky D, Sheth N, Feltz J, Contaifer D Jr, Wijesinghe D, Reed J, Roberts C, Qayyum R, Buck G, Neale M, Toor A

doi: 10.1371/

Allergic Diseases

Comparison of bronchial and nasal allergen provocation in children and adolescents with bronchial asthma and house dust mite sensitization

Pediatr Allergy Immunol.

Fischl A, Eckrich J, Passlack V, Klenke S, Hartmann D, Herrmann E, Schulze J, Zielen S

doi: 10.1111/pai.13147.

Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion

Transpl Infect Dis.

Triplett BM, Muller B, Kang G, Ying L, Cross SJ, Moen J, Cunningham L, Janssen W, Mamcarz E, Shook DR, Srinivasan A, Choi J, Hayden RT, Leung W

doi: 10.1111/tid.12823.

Atopic Dermatitis

House dust mites as potential carriers for IgE sensitisation to bacterialantigens

Allergy

Dzoro S, Mittermann I, Resch Y, Vrtala S, Nehr M, Hirschl AM, Wikberg G, Lundeberg L, Johansson C, Scheynius A, Valenta R

doi: 10.1111/all.13260.

Related content

Der p 1-specific regulatory T cell response during house dust mite allergen immunotherapy

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy

The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

A 300°IR sublingual tablet is an effective, safe treatment for house-dust-mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized Phase III clinical trial

Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides: Understanding randomness in alloreactivity incidence following stem cell transplantation

Comparison of bronchial and nasal allergen provocation in children and adolescents with bronchial asthma and house dust mite sensitization

Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared to CD3-targeted T-cell depletion

House dust mites as potential carriers for IgE sensitisation to bacterialantigens